Advanced Breast Cancer and Its Prevention by Screening
Author Information
Author(s): H.J. de Koning, B.M. van Ineveld, J.C.J.M. de Haes, G.J. van Oortmarssen, J.G.M. Klijn, P.J. van der Maas
Primary Institution: Erasmus Universiteit Rotterdam
Hypothesis
The study aims to quantify the impact of breast cancer screening on the prevention of advanced disease and its associated morbidity.
Conclusion
Breast cancer screening significantly reduces the occurrence of advanced disease, leading to improved quality of life and cost savings.
Supporting Evidence
- Screening can reduce breast cancer mortality by 16% in the Dutch population.
- Women with advanced breast cancer experience a 39% loss in quality of life compared to healthy women.
- The total medical cost from diagnosis of advanced disease until death is approximately 17,100 US dollars per woman.
- Almost half of the annual cost of screening will be offset by savings in the cost for advanced disease.
- Quality of life improvements account for 70% of the total gain in quality of life from screening.
Takeaway
This study shows that screening for breast cancer can help catch the disease early, which means women can live better lives and spend less on treatment.
Methodology
Patient files from three hospitals were analyzed to assess treatment and quality of life for women with advanced breast cancer.
Potential Biases
Potential selection bias in the patient files analyzed.
Limitations
The study may not account for all variables affecting quality of life and treatment costs, and results may not be generalizable to other countries.
Participant Demographics
All participants were female breast cancer patients who died from the disease between 1985 and 1989.
Statistical Information
Confidence Interval
27-45%
Want to read the original?
Access the complete publication on the publisher's website